Cellectis SA ADR buy Quitte
Start price
29.02.16
/
50%
€21.07
Target price
18.03.16
€24.35
Performance (%)
15.63%
End price
18.03.16
€24.36
Summary
This prediction ended on 18.03.16 with a price of €24.36. The prediction had a final performance of 15.63%. Quitte has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cellectis SA ADR | -2.367% | -2.367% | 157.813% | 104.969% |
| iShares Core DAX® | -0.372% | 8.404% | 6.759% | 47.912% |
| iShares Nasdaq 100 | 2.269% | 15.232% | 36.176% | 94.084% |
| iShares Nikkei 225® | 1.433% | 14.424% | 43.114% | 64.804% |
| iShares S&P 500 | 1.216% | 10.492% | 27.276% | 66.763% |
Comments by Quitte for this prediction
In the thread Cellectis SA ADR diskutieren
gutes Rating und eventuell ein Boden
Shares of Cellectis SA (NASDAQ:CLLS) have received a consensus broker rating score of 1.00 (Strong Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. Four analysts have rated the stock with a strong buy recommendation.
(Zielkurs erreicht)

